The Clean Margin in Diabetic Foot Osteomyelitis: Conceptual Appeal, Practical Uncertainty

Area of Science:

• Infectious Diseases
• Surgical Oncology
• Diabetic Foot Management

Background:

• Updated guidelines suggest individualized antimicrobial treatment for diabetic foot osteomyelitis (DFO) based on resection margins.
• This approach shifts from traditional broad-spectrum antibiotic use to targeted therapy.
• However, the concept of resection margins in DFO is not well-defined or consistently measured.

Purpose of the Study:

• To evaluate the current understanding and application of resection margins in diabetic foot osteomyelitis treatment.
• To highlight the need for standardized definitions and validation of margin assessment methods.

Main Methods:

• Review of current guidelines and literature on DFO management and resection margin assessment.
• Analysis of the evolution of the resection margin concept in DFO from descriptive to categorical assessments.
• Examination of the discordance between surgical, histopathological, and microbiological assessments of margins.

Main Results:

• Resection margin assessment in DFO lacks standardized definitions and consistent measurement methods.
• Current recommendations are based on limited data with uncertain residual infection ascertainment.
• Interdisciplinary assessments (surgical, histopathological, microbiological) are often discordant, impacting treatment reliability.

Conclusions:

• The current approach to tailoring DFO treatment based on resection margins is conceptually appealing but lacks robust validation.
• Standardized definitions and prospective validation of margin assessment are crucial before routine clinical implementation.
• Further research is needed to refine the operationalization and reliability of resection margin assessment in DFO.